I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!
I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!
And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic
Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop
In this week's issue of The Savvy Diabetic: GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs Work...
Savvy Updates 10/7/24: Somatostatin Protects Against Sudden BG Drops, Sernova’s Cell Pouch, A Spoonful of Laughter
It was a quiet week for diabetes news, in this issue of The Savvy Diabetic: Somatostatin May Protect Against Sudden BG Drops Sernova's Cell Pouch Contains Vascularized, Functioning Islets > 5 years A Spoonful of Laughter for dStimatize.org (diaTribe) Potential...
Savvy Updates 9/30/24: Stem Cells, New CGM? Biomea Fusion, Wink Therapeutics, Sensulin, Heat/Dust Affects T1D, Gina Pillina T1D Artist
In this week's issue of The Savvy Diabetic: Stem cells Reverse T1D Microtech Linx CGM (a fail?) FDA Releases Clinical Hold on Biomea Fusion's BMF-219 StartUp Health Podcast: WiNK Therapeutics & Sensulin Heat/dust Increase Diabetes...
Savvy Updates, 9/23/24: G7 Geofencing Fix, Senseonics Eversense 365, Abbott Ramps Libre3 Production, AI Predicts Retinopathy, SuperCell Medicines, Stem Cell-Enabled Therapy, How to Appeal Insurance Denial, T1D & Brain Development, FTC & PMBs Sue Each Other, ChatGPT for Diagnosis
In this week's issue of The Savvy Diabetic: Geofencing/Dexcom G7 Update! with Jake Leach Senseonics Gets FDA Clearance for 1-year CGM Abbott Ramps Up Libre 3 Production AI Model to Predict Diabetic Retinopathy GC Therapeutics "Supercell" Medicines...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder
Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Savvy Updates 9/9/24: Abbott Lingo 14-day OTC Sensor, Embecta Patch Pump FDA Clearance, Beta Bionics Partners with Abbott Libre3, Mental Resilience, TCOYD on Kidney Disease
Abbott debuts Lingo over-the-counter CGM in the US by Elise Reuter for MedTechDive.com, 6 September 2024. Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor. Abbott’s Lingo is intended to show...
Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely
Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89...
Savvy Updates 8/26/24: T1D Risk Higher for T1D Dads, DreaMed endo.digital, Focus on Art: Appleton Artwork ,Coffee/Caffeine
Risk for Developing Type 1 Diabetes Doubled With Paternal Link by Lori Solomon for HealthDay.com, 16 August 2024. Individuals are less likely to have type 1 diabetes if their mother has the condition than if their father is affected, according to a study scheduled to...
Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED
Tandem warns iPhone app still draining insulin pump batteries by Elise Reuter for MedTechDive.com, 15 August 2024. Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected...
Savvy Updates, 8/12/24: Medtronic Simplera CGM Approved, Medtronic/Abbott CGM Integration, Diabeloop Study on Disparities in Insulin Needs Between Sexes, Accu-Chek SmartGuide Approved in Europe, Most Downloaded Apps to Manage T1D
FDA approves next-generation CGM with two-step insertion process by Jill Rollet for Healio.com/endocrinology, 7 August 2024. FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes. The Simplera CGM (Medtronic) is a CGM...
More Diabetes Blogs